| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/16/2009 | CN101530515A Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |
| 09/16/2009 | CN101530514A A salve for treating zoster |
| 09/16/2009 | CN101530509A Swim bladder kidney-reinforcing pill preparation and method for preparing same |
| 09/16/2009 | CN101530508A Traditional Chinese medicine for treating ovarian cancer |
| 09/16/2009 | CN101530506A Method for analyzing poisonous clear tablet |
| 09/16/2009 | CN101530505A Effect of medical glue blood-nourishing syrup on freckle removal, senescence resistance and increment of skin nutrition |
| 09/16/2009 | CN101530501A Traditional Chinese medicine for treating diabetic anemia |
| 09/16/2009 | CN101530500A Therapeutic effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530499A Prevention effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530498A Improvement effect of blood-nourishing and brain-refreshing granules on cerebral microcirculatory disturbance |
| 09/16/2009 | CN101530494A Substance for intestinal tract lavation and toxin expelling and preparation method thereof |
| 09/16/2009 | CN101530493A Medicament combination for curing respiratory diseases and application thereof |
| 09/16/2009 | CN101530490A Traditional Chinese medicine for treating bladder cancer |
| 09/16/2009 | CN101530484A Blood-activating bone-strengthening plaster |
| 09/16/2009 | CN101530478A Chinese medicinal composition with efficacies of preventing myocardial infarct and cerebral infarct, dissolving and eliminating thrombus, activating blood and dissolving stasis, and resisting ageing |
| 09/16/2009 | CN101530476A Chinese medicinal preparation for treating malignant tumor of palatum |
| 09/16/2009 | CN101530470A Medicament for treating rheumatism and rheumatoid disease, and preparing method thereof |
| 09/16/2009 | CN101530468A Chinese medicinal preparation for treating gum cancer |
| 09/16/2009 | CN101530462A Composition for treating eczema and preparation method thereof |
| 09/16/2009 | CN101530461A Traditional Chinese medicine for treating nasopharyngeal cancer |
| 09/16/2009 | CN101530448A External Chinese medicinal plaster for treating traumatic injury |
| 09/16/2009 | CN101530434A Method for preparing silkworm powder, pupa powder or pupa serum powder containing antibacterial peptide and application of same |
| 09/16/2009 | CN101530433A Method for preparing oyster functional oral liquid |
| 09/16/2009 | CN101530432A Method for producing degreased concentrated solution of tussah male moth |
| 09/16/2009 | CN101530431A Method for preparing biological agent for treating wet beriberi |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN101530429A New use of clarias lazera |
| 09/16/2009 | CN101530428A Artificial bezoar and preparation method thereof |
| 09/16/2009 | CN101530427A Pharmaceutical composition for promoting hematopoiesis and preparation method thereof |
| 09/16/2009 | CN101530426A Kazakstan skeleton softening medicine |
| 09/16/2009 | CN101530425A Application of refined seal oil to preparation of medicines for treating chronic renal failure |
| 09/16/2009 | CN101530040A Essential plant fragrance smell area capable of improving depression symptoms and construction method thereof |
| 09/16/2009 | CN100540657C Endothelial cells derived from primate embryonic stem cells |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588781 oral administering a mixture powders comprising a dissolved whey protein to increase release the bioactive carotenoid, polyphenol, vitamins, flavonoid, isoflavone, ceramide |
| 09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588759 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
| 09/15/2009 | US7588752 Derived from milk protein casein; for use in dentistry |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2625811A1 Microrna mediated oncolytic targeting |
| 09/11/2009 | WO2009111778A2 Lymph nodes as a site for regeneration |
| 09/11/2009 | WO2009111396A1 Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof |
| 09/11/2009 | WO2009111030A1 Use of mesenchymal stem cells for treating genetic diseases and disorders |
| 09/11/2009 | WO2009110940A2 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 09/11/2009 | WO2009110646A1 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 09/11/2009 | WO2009110644A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/11/2009 | WO2009052323A3 Manufacture, compositions and uses of coagulationfactor viia modulator |
| 09/11/2009 | WO2009022842A3 Pharmaceutical composition for preventing and treating cell proliferative disease comprising mixture of feather of birds and scale of fish as an active ingredient |
| 09/11/2009 | WO2008096171A3 Natural laxative composition comprising prunes, raisins, apricots, dates, figs, olive oil, senna and honey |
| 09/11/2009 | WO2006021006A3 Non-human animal models for diabetic complications and their uses |
| 09/11/2009 | CA2717626A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/11/2009 | CA2717498A1 Use of mesenchymal stem cells for treating genetic diseases and disorders |
| 09/11/2009 | CA2713728A1 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227535 Process for producing natural immunobiotic extract and uses thereof |
| 09/10/2009 | US20090227488 Class of bioactive glycoprotein |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090227000 Chimeric adenoviruses for use in cancer treatment |
| 09/10/2009 | US20090226536 Methods and materials relating to enhanced production of dopamine neurons |
| 09/10/2009 | US20090226535 Food intake regulator |
| 09/10/2009 | US20090226534 Bone paste composition |
| 09/10/2009 | US20090226533 Functional Milk Fraction for Use Against Dental Erosion |
| 09/10/2009 | US20090226523 Demineralized bone matrix compositions and methods |
| 09/10/2009 | US20090226519 Hydrogel bioscaffoldings and biomedical device coatings |
| 09/10/2009 | US20090226508 Methods And Materials For Immunization Against Cancer |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226489 Viral vaccine composition, process and methods of use |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226418 Food Products Comprising Probiotic Micro-Organisms and Antibodies |
| 09/10/2009 | US20090226406 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/10/2009 | US20090226405 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CUPREDOXINS AND CpG RICH DNA |
| 09/10/2009 | US20090226404 Methods for Generating Antigen-Specific Effector T Cells |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226402 Compositions and Methods of Vascular Injury Repair |
| 09/10/2009 | US20090226401 Methods and compositions for the treatment of parkinson's disease |
| 09/09/2009 | EP2098589A2 Immune cell modification method and cell modification device |
| 09/09/2009 | EP2098240A1 Agent for promoting healing of living body |
| 09/09/2009 | EP2098239A1 Food intake regulator |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097452A1 Delivery of binding molecules to induce immunomodulation |
| 09/09/2009 | EP2097088A2 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 09/09/2009 | EP2097087A2 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 09/09/2009 | EP1965809B1 Compositions to improve gut health and animal performance comprising beta-glucans and alfa-fucans |
| 09/09/2009 | EP1885382A4 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/09/2009 | EP1858533A4 Use of amniotic fluid (af) in treating ocular disease and injury |
| 09/09/2009 | EP1765370B1 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 09/09/2009 | EP1661982B1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 09/09/2009 | EP1578958B1 Method for suppressing immune system response to transplanted tissue or cells |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |